ExodusPoint Capital Management’s Intercure INCR Stock Holding History

ExodusPoint Capital Management’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48,089	Closed	-$216K	–	1855
2022 Q3	$216K	Buy	+48,089	New	+$262K	﹤0.01%	1622

Other funds holding INCR

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ExodusPoint Capital Management's INCR Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of Intercure (INCR) in Q4 2022, closing a stake of 48,089 shares — an estimated $216K sold.

ExodusPoint Capital Management first reported a position in INCR in Q3 2022 and held it in 1 quarter. The position peaked at $216K in Q3 2022. 15 funds tracked by Wall St. Rank hold INCR as of Q4 2022.

ExodusPoint Capital Management reported no remaining Intercure position as of Q4 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 48,089 Intercure shares in Q4 2022, an estimated $216K.
ExodusPoint Capital Management first reported a position in Intercure in Q3 2022 and held it in 1 quarter.
ExodusPoint Capital Management's Intercure position peaked at $216K in Q3 2022.
15 funds tracked by Wall St. Rank held Intercure as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.